Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI
Clinical trial NCT02437253 · COMPLETED
Trial details
- NCT number
- NCT02437253
- Sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-07-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.